Antivenoms Market by Species (Scorpion, Snakes, Spiders), Type (Monovalent Antivenom, Polyvalent Antivenom) - Global Forecast 2024-2030
The Antivenoms Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.87 billion in 2024, at a CAGR 7.17% to reach USD 4.37 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antivenoms Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antivenoms Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antivenoms Market, highlighting leading vendors and their innovative profiles. These include Amsaal LLC, BB - NCIPD Ltd., Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH., BTG International Inc., Creative BioMart, CSL, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Pharma, Inosan Biopharma, Institute of Vaccines and Medical Biologicals, Instituto Clodomiro Picado, KM Biologics, Laboratorios Silanes, S.A. de C.V, Lexicare Pharma Pvt. Ltd., Medtoxin Venom Laboratories, LLC, Merck & Co., Inc., MicroPharm, Padula Serums Pty Ltd., Pfizer Inc., Rare Disease Therapeutics, Inc., Serum Institute of India Pvt. Ltd., Shanghai Serum Bio-technology Co., Ltd., and VINS Bioproducts Ltd..
Market Segmentation & Coverage
This research report categorizes the Antivenoms Market to forecast the revenues and analyze trends in each of the following sub-markets:
Species
Scorpion
Monovalent Antivenom
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Antivenoms Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antivenoms Market?
- What are the technology trends and regulatory frameworks in the Antivenoms Market?
- What is the market share of the leading vendors in the Antivenoms Market?
- Which modes and strategic moves are suitable for entering the Antivenoms Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Antivenoms Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing incidences of snake bites
- 5.1.1.2. Rising awareness of antivenoms available as first-aid
- 5.1.1.3. Increasing improvements in healthcare infrastructure in rural areas
- 5.1.2. Restraints
- 5.1.2.1. High production cost of antivenoms
- 5.1.3. Opportunities
- 5.1.3.1. Technical advancements in antivenoms production
- 5.1.3.2. Improvement in distribution networks of antivenoms in countries
- 5.1.4. Challenges
- 5.1.4.1. Lack of regulatory norms for antivenom manufacturing
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Antivenoms Market, by Species
- 6.1. Introduction
- 6.2. Scorpion
- 6.3. Snakes
- 6.4. Spiders
- 7. Antivenoms Market, by Type
- 7.1. Introduction
- 7.2. Monovalent Antivenom
- 7.3. Polyvalent Antivenom
- 8. Americas Antivenoms Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Antivenoms Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Antivenoms Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Amsaal LLC
- 12.1.2. BB - NCIPD Ltd.
- 12.1.3. Bharat Serums and Vaccines Limited (BSV)
- 12.1.4. Boehringer Ingelheim International GmbH.
- 12.1.5. BTG International Inc.
- 12.1.6. Creative BioMart
- 12.1.7. CSL
- 12.1.8. Haffkine Bio-Pharmaceutical Corporation Ltd.
- 12.1.9. Incepta Pharma
- 12.1.10. Inosan Biopharma
- 12.1.11. Institute of Vaccines and Medical Biologicals
- 12.1.12. Instituto Clodomiro Picado
- 12.1.13. KM Biologics
- 12.1.14. Laboratorios Silanes, S.A. de C.V
- 12.1.15. Lexicare Pharma Pvt. Ltd.
- 12.1.16. Medtoxin Venom Laboratories, LLC
- 12.1.17. Merck & Co., Inc.
- 12.1.18. MicroPharm
- 12.1.19. Padula Serums Pty Ltd.
- 12.1.20. Pfizer Inc.
- 12.1.21. Rare Disease Therapeutics, Inc.
- 12.1.22. Serum Institute of India Pvt. Ltd.
- 12.1.23. Shanghai Serum Bio-technology Co., Ltd.
- 12.1.24. VINS Bioproducts Ltd.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. ANTIVENOMS MARKET RESEARCH PROCESS
- FIGURE 2. ANTIVENOMS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANTIVENOMS MARKET DYNAMICS
- FIGURE 7. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2030 (%)
- FIGURE 8. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook